Pharma Reviews: India starts hunt for alternatives to China to source over 1k items

Sources said the pharma industry expects supply disruption of 16 molecules, which includes antibiotics such as chloramphenicol, erythromycin, ...
Read more: India starts hunt for alternatives to China to source over 1k items

Pharma Reviews: 'Sustainable packaging in pharma still a long way to go': AVPS Chakravarthi, World Packaging ...

Also, I am not wrong if I say that the growth of Indian pharmaceuticals packaging industry is directly linked to growth of pharmaceutical manufacturing ...
Read more: 'Sustainable packaging in pharma still a long way to go': AVPS Chakravarthi, World Packaging ...

Pharma Reviews: Movers & Shakers: Top 10 stocks which moved most this week; India Cements, Tata Motors top ...

Tracking weakness in global markets, Indian indices witnessed a knee-jerk ... The company reported a profit after tax at Rs 634.5 crore in the quarter ... Report with VAl status from the US FDA," the drug firm said in a filing to BSE.
Read more: Movers & Shakers: Top 10 stocks which moved most this week; India Cements, Tata Motors top ...

US FDA News: Coronavirus (COVID-19) Update: FDA Issues New Policy to Help Expedite Availability of Diagnostics

Coronavirus (COVID-19) FDA Issues New Policy to Help Expedite Availability of Diagnostics
Read more: Coronavirus (COVID-19) Update: FDA Issues New Policy to Help Expedite Availability of Diagnostics

Pharma Reviews: Markets in the time of Coronavirus Outbreak

Following the trend of rout in global indices, Indian markets have also crashed ... Coronavirus outbreak has caused supply problem for pharmaceutical ...
Read more: Markets in the time of Coronavirus Outbreak

Pharma Reviews: Pharma sector regulator directs States, UTs to monitor raw material supply to manufacture medicines

... India's pharmaceutical sector regulator, National Pharmaceutical Pricing Authority (NPPA), has written to all states and Union Territories to keep a ...
Read more: Pharma sector regulator directs States, UTs to monitor raw material supply to manufacture medicines

Pharma Reviews: Coronavirus outbreak: Don't panic over supplies, says pharma industry

Amid rising cases of the novel coronavirus (Covid-19), the captains of Indian pharma industry on Friday said there was no reason to panic over drug ...
Read more: Coronavirus outbreak: Don't panic over supplies, says pharma industry

Pharma Reviews: Hyderabad's IICT can reverse engineer COVID-19 drug in 3 months

In case the pharmaceutical companies refuse to sell or share the drug technology in India, Parliament has the right to invoke 'compulsory licensing' ...
Read more: Hyderabad's IICT can reverse engineer COVID-19 drug in 3 months

Pharma Reviews: USFDA warnings: Concerns remain even as India fares better than US

Heightened regulatory scrutiny by the US drug regulator for Indian pharma is a concern for the industry. However, long-term data shows that Indian ...
Read more: USFDA warnings: Concerns remain even as India fares better than US

Pharma Reviews: Is Indian economy equipped to deal with the global disruption caused by coronavirus?

India's automobile and pharma sectors, which depend on China for raw materials, are already feeling the pinch. PM Narendra Modi's government said ...
Read more: Is Indian economy equipped to deal with the global disruption caused by coronavirus?

Pharma Reviews: Indian pharma industry: From cultural practices to quality intensive; what lies ahead?

It is a matter of pride for India and a feather in our economy's hat that the Indian pharmaceutical industry is the world's third largest by volume, today.
Read more: Indian pharma industry: From cultural practices to quality intensive; what lies ahead?

Pharma Reviews: Govt completes molecular mapping of active pharma ingredients

The Indian pharma industry heavily relies on imports of bulk drugs (APIs and intermediates), with more than 50 per cent of API coming from China.
Read more: Govt completes molecular mapping of active pharma ingredients

US FDA News: FDA Approves First Generic of Daraprim

FDA has approved an application for first generic of Daraprim (pyrimethamine).
Read more: FDA Approves First Generic of Daraprim

Pharma Reviews: What is the impact of Coronavirus on Indian Economy?

For automotive parts and fertilisers China's share in India's import is more than 25%. Around 65 to 70% of active pharmaceutical ingredients and ...
Read more: What is the impact of Coronavirus on Indian Economy?

Pharma Reviews: 'Centre must aid firms to fight virus impact'

Mumbai: The central government should immediately step in to help out the Indian industry—especially the pharmaceutical sector— affected by the ...
Read more: 'Centre must aid firms to fight virus impact'

Pharma Reviews: INTERVIEW: Cadila Health MD pins growth on diabetes, anaemia drugs

Patel believes the company can see double-digit annual growth in earnings till 2023 with its focus on the Indian and the US drug markets.
Read more: INTERVIEW: Cadila Health MD pins growth on diabetes, anaemia drugs

Pharma Reviews: Shilpa Medicare's gaining streak may sustain post 74% jump in Feb

MUMBAI – Disruption in supply of raw materials to the pharmaceutical ... presents a good opportunity for players like Indian manufacturers to chip in.
Read more: Shilpa Medicare's gaining streak may sustain post 74% jump in Feb

Pharma Reviews: Tough times for import dependent pharma firms

Hyderabad: Hit by the outbreak of COVID-19 and subsequent disruption in the supply chain, the Indian drug industry might see an increase in prices ...
Read more: Tough times for import dependent pharma firms

Pharma Reviews: Indian pharmaceutical companies faces challenges at home and abroad

It's not going to be an easy recovery for the pharma sector. The home market has started to slacken, while the coronavirus outbreak has raised ...
Read more: Indian pharmaceutical companies faces challenges at home and abroad

Pharma Reviews: Indian drug regulatory processes aligned with global standards, says DCGI

India is far ahead in making accessible, affordable medicines and is very serious about the quality of drugs, according to him. Companies that do not ...
Read more: Indian drug regulatory processes aligned with global standards, says DCGI

Pharma Reviews: Pratap B Mehta says rulers want fear & cruelty in Delhi, Najeeb Jung blames Amit Shah

Biju Dominic | CEO, Final Mile Consulting, a behaviour architecture firm ... He explains how the Indian pharma industry is heavily reliant on China for ...
Read more: Pratap B Mehta says rulers want fear & cruelty in Delhi, Najeeb Jung blames Amit Shah

Pharma Reviews: Proposed cess on import of APIs stokes supply disruption fears

NEW DELHI: A central panel has proposed that India impose a cess on imported Active Pharmaceutical Ingredients (APIs), which are used to make ...
Read more: Proposed cess on import of APIs stokes supply disruption fears

Pharma Reviews: Viral Threat: Indian pharma catches China's COVID sickness

Concern has been expressed over the impact of the COVID-19, or the novel Coronavirus, on supplies in India, particularly the pharmaceutical industry.
Read more: Viral Threat: Indian pharma catches China's COVID sickness

Pharma Reviews: Killer medicine

For more than 30 years, India has been the largest supplier of generic medicines in the world. However, the country's pharma industry has never ...
Read more: Killer medicine

US FDA News: Coronavirus (COVID-19) Supply Chain Update

Coronavirus (COVID-19) Supply Chain Update
Read more: Coronavirus (COVID-19) Supply Chain Update

US FDA News: Coronavirus (COVID-19) Update: No outbreak-related shortages identified, FDA continuing to closely monitor supply chain

Coronavirus Update: No outbreak-related shortages identified, FDA continuing to closely monitor supply chain
Read more: Coronavirus (COVID-19) Update: No outbreak-related shortages identified, FDA continuing to closely monitor supply chain

US FDA News: FDA Reminds Patients that Devices Claiming to Clean, Disinfect or Sanitize CPAP Machines Using Ozone Gas or UV Light Have Not Been FDA Authorized

FDA informs patients and health care providers that devices claiming to clean, disinfect or sanitize CPAP devices or accessories using ozone gas or UV light are not legally marketed for this use by the FDA.
Read more: FDA Reminds Patients that Devices Claiming to Clean, Disinfect or Sanitize CPAP Machines Using Ozone Gas or UV Light Have Not Been FDA Authorized

US FDA News: King Systems Recalls King Vision Video Laryngoscope Adapter Size ½ Due to a Display of The Reversed Image

The device shows an image on the display while examining a patient’s upper airway. A reverse image is displayed which could cause potential injury.
Read more: King Systems Recalls King Vision Video Laryngoscope Adapter Size ½ Due to a Display of The Reversed Image

US FDA News: Potential Risks Associated With The Use of Ozone and Ultraviolet (UV) Light Products for Cleaning CPAP Machines and Accessories: FDA Safety Communication

The FDA wants to make consumers and health care providers aware that, to date, the FDA has not authorized for market any products using ozone gas or ultraviolet (UV) light to clean, disinfect, or sanitize continuous positive airway pressure (CPAP) devices and accessories.
Read more: Potential Risks Associated With The Use of Ozone and Ultraviolet (UV) Light Products for Cleaning CPAP Machines and Accessories: FDA Safety Communication

US FDA News: American Health Packaging Issues Voluntary Nationwide Recall of Ranitidine Tablets, USP 150 mg, 100 Count Unit Dose Blisters Due to the Detection of N-nitrosodimethylamine (NDMA) Impurity

American Health Packaging has voluntarily recalled eleven (11) lots of Ranitidine Tablets, USP 150 mg, 100 count Unit Dose Blisters to the consumer level due to the potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.
Read more: American Health Packaging Issues Voluntary Nationwide Recall of Ranitidine Tablets, USP 150 mg, 100 Count Unit Dose Blisters Due to the Detection of N-nitrosodimethylamine (NDMA) Impurity

Pharma Reviews: Coronavirus takes a toll on Indian businesses -- pharma, electronics and other industries stare at ...

With between 10 and 30 per cent of components imported from China, the auto sector is likely to be seriously affected by the Coronavirus outbreak.
Read more: Coronavirus takes a toll on Indian businesses -- pharma, electronics and other industries stare at ...

Pharma Reviews: Cipla gets first US FDA warning letter ever for Goa plant

Unlike other Indian pharmaceutical firms, Cipla has been one of the best among Indian generic drugmakers in terms of regulatory compliance. Though ...
Read more: Cipla gets first US FDA warning letter ever for Goa plant

Pharma Reviews: 'Limited immediate risk from Covid-19 to India pharma sector'

Mumbai: The immediate risk to the Indian pharma industry from the supply shortages of key raw materials from China due to coronavirus outbreak is ...
Read more: 'Limited immediate risk from Covid-19 to India pharma sector'

Pharma Reviews: What are APIs and how they threaten India's status of a 'pharmacy to the world'

Despite being a leading supplier of high-quality medicines to several countries, Indian pharmaceutical industry is highly dependent on China for raw ...
Read more: What are APIs and how they threaten India's status of a 'pharmacy to the world'

Pharma Reviews: Is specialty business 'a go or a no-go' segment for pharma companies?

Indian pharma companies have been toying with different strategies to build their US business as the traditional low-cost model of selling generic ...
Read more: Is specialty business 'a go or a no-go' segment for pharma companies?

Pharma Reviews: Trade in the time of Coronavirus: Sectors overdependent on Chinese imports face a grim reality

The sector that is under severe stress is the electronics industry. ... 85% of active pharmaceutical ingredient (API) imported by India are from China.
Read more: Trade in the time of Coronavirus: Sectors overdependent on Chinese imports face a grim reality

Pharma Reviews: Cipla share price falls 5 per cent after warning letter from US Food and Drug Administration

The recent fall in pharma shares has also been nudged by Coronavirus which might impact the Indian pharma industry if the halt in manufacturing ...
Read more: Cipla share price falls 5 per cent after warning letter from US Food and Drug Administration

Pharma Reviews: "I'll tell you exactly where to invest, and how to invest": Trump to India Inc

Talking to leading CEOs and promoters from Indian corporate sector at the US ... We just did a lot of business with India where they are buying $3 billion ... opinion about an Indian pharmaceutical company setting up manufacturing ...
Read more: "I'll tell you exactly where to invest, and how to invest": Trump to India Inc

Pharma Reviews: Informa Markets in India, Announces the Launch of 'Maternal and Child Nutrition' Conference With ...

This conference is presented by DSM Nutrition Company. ... supplier of vitamins and nutritional premixes to the food and pharmaceutical industries.
Read more: Informa Markets in India, Announces the Launch of 'Maternal and Child Nutrition' Conference With ...

Pharma Reviews: Coronavirus: No significant immediate risk to Indian pharma sector say officials

The immediate risk to the Indian pharma industry from the supply shortages of key raw materials from China due to coronavirus outbreak is limited, ...
Read more: Coronavirus: No significant immediate risk to Indian pharma sector say officials

Pharma Reviews: CNBC-TV18 Market Highlights: Sensex ends mildly lower, Nifty below 11800; RIL, HDFC Bank top ...

Indian shares ended with mild losses on Tuesday as Asian markets ... Last week, ICRA revised its outlook on the Indian domestic pharma industry ...
Read more: CNBC-TV18 Market Highlights: Sensex ends mildly lower, Nifty below 11800; RIL, HDFC Bank top ...

US FDA News: UPDATE: Reduce the Risk of Cardiac Surgery Infection While Using the LivaNova Heater-Cooler System 3T: FDA Safety Communication

FDA reminds health care providers and staff of actions to take to reduce the risk of cardiac surgery infection when using the LivaNova Heater-Cooler System 3T.
Read more: UPDATE: Reduce the Risk of Cardiac Surgery Infection While Using the LivaNova Heater-Cooler System 3T: FDA Safety Communication

US FDA News: Tytek Medical Recalls TM-317 PneumoDart-Pneumothorax Needle Due to Fully and Partially Blocked Needles

The needle is used to remove air from the lung cavity. If the needle is blocked, emergency treatment is delayed which can lead to heart or lung failure.
Read more: Tytek Medical Recalls TM-317 PneumoDart-Pneumothorax Needle Due to Fully and Partially Blocked Needles

US FDA News: FDA Takes New Steps to Increase the Safety of Laparoscopic Power Morcellators when used in Gynecologic Surgeries

FDA takes several steps to make the use of laparoscopic power morcellators safer in gynecologic surgeries: grants marketing authorization for updated labeling, releases draft guidance and issues a Safety Communication.
Read more: FDA Takes New Steps to Increase the Safety of Laparoscopic Power Morcellators when used in Gynecologic Surgeries

US FDA News: UPDATE: The FDA recommends performing contained morcellation in women when laparoscopic power morcellation is appropriate

The U.S. Food and Drug Administration (FDA) is updating our 2014 safety communication on laparoscopic power morcellators to provide new information on the safe and effective use of laparoscopic power morcellation for gynecologic procedures.
Read more: UPDATE: The FDA recommends performing contained morcellation in women when laparoscopic power morcellation is appropriate

Pharma Reviews: Drug regulator offers to airlift raw materials from Coronovirus-hit China

The Drug Controller General of India (DCGI) has written to Indian pharmaceutical trade bodies and industry associations with the offer of extending ...
Read more: Drug regulator offers to airlift raw materials from Coronovirus-hit China

Pharma Reviews: 'Limited immediate risk from Covid-19 to India pharma sector'

Mumbai, Feb 24 (IANS) The immediate risk to the Indian pharma industry from the supply shortages of key raw materials from China due to ...
Read more: 'Limited immediate risk from Covid-19 to India pharma sector'

Pharma Reviews: Govt stops short of imposing export ban on essential drugs, asks industry to self-regulate supply

... the export of drugs are concerned so that we don't go out of stock,” said Sudarshan Jain, Secretary General of Indian Pharmaceutical Alliance (IPA), ...
Read more: Govt stops short of imposing export ban on essential drugs, asks industry to self-regulate supply

Pharma Reviews: Coronavirus-induced lockdown in China can put the brakes on pharma funds

On Thursday, Icra revised its outlook on Indian domestic pharma from stable ... The rating agency pointed out that domestic pharma industry is heavily ...
Read more: Coronavirus-induced lockdown in China can put the brakes on pharma funds

Pharma Reviews: Cipla: Breath of new air

This also explains the sustained relevance of pharma major Cipla, which ... at 19%, outpacing the 11% growth exhibited by the overall India market.
Read more: Cipla: Breath of new air

Pharma Reviews: Which firms will profit from Coronavirus outbreak?

It is also unclear if Indian pharmaceutical firms will be able to benefit from the ... Other companies like Aurobindo Pharma, Cadila Healthcare and Sun ...
Read more: Which firms will profit from Coronavirus outbreak?

US FDA News: Coronavirus Update: FDA steps to ensure quality of foreign products

Coronavirus Update: FDA steps to ensure quality of foreign products
Read more: Coronavirus Update: FDA steps to ensure quality of foreign products

US FDA News: FDA approves first generic of ProAir HFA

FDA has approved an application for the first generic of ProAir HFA (albuterol sulfate) Inhalation Aerosol.
Read more: FDA approves first generic of ProAir HFA

Pharma Reviews: No cause for panic for industry, trade; Assocham on Coronavirus impact

MANGALURU: There is absolutely no need for any panic, as the Indian industry and trade, including the pharmaceuticals, are readying to manage the ...
Read more: No cause for panic for industry, trade; Assocham on Coronavirus impact

Pharma Reviews: Over 8600 pharma firms claim income tax deductions on 'gifts' given to doctors

NEW DELHI : More than 8,600 Indian pharmaceutical companies have claimed income tax deduction on the freebies they give to doctors as “sales ...
Read more: Over 8600 pharma firms claim income tax deductions on 'gifts' given to doctors

Pharma Reviews: Coronavirus: Find out how much Indian pharma is exposed to Chinese Imports

February 22, 2020: The credit rating agency, ICRA has revised its outlook on the Indian pharmaceutical industry from stable to negative in view of the ...
Read more: Coronavirus: Find out how much Indian pharma is exposed to Chinese Imports

US FDA News: Abbott Initiates Voluntary Recall of Specific Lots of Two Coronary Catheters

Abbott has voluntarily recalled specific lots of two catheters used in coronary angioplasty procedures: the NC Trek RX Coronary Dilatation Catheter and the NC Traveler Coronary Dilatation Catheter, balloon diameters 4.0mm, 4.5mm and 5.0mm. This recall does not affect patients who have successfully u
Read more: Abbott Initiates Voluntary Recall of Specific Lots of Two Coronary Catheters

Pharma Reviews: Tax deductions for sales promotions, gifts of pharma companies on Madras HC radar

Pharmaceutical companies in India claiming tax deductions for “sales promotion” as well as “gifts” are on the radar of the Madras High Court for ...
Read more: Tax deductions for sales promotions, gifts of pharma companies on Madras HC radar

Pharma Reviews: Prolonged coronavirus outbreak to impact Indian industry seriously, says CRISIL

The report pointed out that sectors such as auto components, pharma bulk ... Moreover, India's steel, paper, leather and textile readymade garments ...
Read more: Prolonged coronavirus outbreak to impact Indian industry seriously, says CRISIL

US FDA News: FDA Takes Action with Indian Government to Protect Consumers From Illicit Medical Products

The FDA announced that in partnership with the Government of India, approximately 500 shipments of illicit and potentially dangerous, unapproved prescription drugs and combination medical devices were stopped from reaching American consumers.
Read more: FDA Takes Action with Indian Government to Protect Consumers From Illicit Medical Products

US FDA News: FDA’s Actions in Response to 2019 Novel Coronavirus at Home and Abroad

FDA is an active partner in the COVID-19 response, working closely with government and public health partners across HHS and international counterparts.
Read more: FDA’s Actions in Response to 2019 Novel Coronavirus at Home and Abroad

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on 2017 National Youth Tobacco Survey results and ongoing FDA efforts to protect youth from the dangers of nicotine and tobacco products

Statement from FDA Commissioner Scott Gottlieb, M.D., on 2017 National Youth Tobacco Survey results and ongoing FDA efforts to protect youth from the dangers of nicotine and tobacco products
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on 2017 National Youth Tobacco Survey results and ongoing FDA efforts to protect youth from the dangers of nicotine and tobacco products

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on developments in the romaine outbreak investigation, recent outbreaks and the use of modern tools to advance food safety

Being able to identify outbreaks is key to being able to take quick action to prevent additional illnesses and find the source of the contamination. In recent years, the FDA and the Centers for Disease Control and Prevention (CDC) have advanced new tools that make it easier and faster to identify outbreaks of human illness and to link them back to the food source that is the culprit responsible for the illnesses. But our improved ability to spot outbreaks has also caused some to question whether we are experiencing more foodborne outbreaks now than in the past.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on developments in the romaine outbreak investigation, recent outbreaks and the use of modern tools to advance food safety

US FDA News: Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new resource guide to support responsible opioid prescribing for pain management in animals

Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new resource guide in support of responsible opioid prescribing for safe, effective pain management in animals
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA’s new resource guide to support responsible opioid prescribing for pain management in animals

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on launch of ‘The Real Cost’ Youth E-Cigarette Prevention Campaign amid evidence of sharply rising use among kids

Statement from FDA Commissioner Scott Gottlieb, M.D., on launch of ‘The Real Cost’ Youth E-Cigarette Prevention Campaign amid evidence of sharply rising use among kids.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on launch of ‘The Real Cost’ Youth E-Cigarette Prevention Campaign amid evidence of sharply rising use among kids

US FDA News: FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications

FDA update on the ongoing investigation into angiotensin II receptor blocker impurities, recalls and current findings.
Read more: FDA warns API manufacturer involved in valsartan recall, provides information for patients taking these medications

US FDA News: Statement from Jeffrey Shuren, M.D., J.D., Director of the FDA’s Center for Devices and Radiological Health on the National Toxicology Program’s report on radiofrequency energy exposure

Statement from Jeffrey Shuren, M.D., J.D., director of the FDA’s Center for Devices and Radiological Health on the recent National Toxicology Program report release on radiofrequency energy exposure
Read more: Statement from Jeffrey Shuren, M.D., J.D., Director of the FDA’s Center for Devices and Radiological Health on the National Toxicology Program’s report on radiofrequency energy exposure

US FDA News: US Marshals seize dietary supplements containing kratom

The U.S. Food and Drug Administration announced today that U.S. Marshals, at the agency’s request, seized nearly 90,000 bottles of dietary supplements labeled as containing kratom. The product, manufactured and held by Dordoniz Natural Products LLC, located in South Beloit, Illinois, is marketed under the brand name RelaKzpro and worth more than $400,000.
Read more: US Marshals seize dietary supplements containing kratom

US FDA News: FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor’s office or clinic

FDA approved Spravato (esketamine) nasal spray, in conjunction with an oral antidepressant, for the treatment of depression in adults with treatment-resistant depression
Read more: FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor’s office or clinic

US FDA News: FDA expands use of Xalkori to treat rare form of advanced non-small cell lung cancer

The U.S. Food and Drug Administration today approved Xalkori (crizotinib) to treat people with advanced (metastatic) non-small cell lung cancer (NSCLC) whose tumors have an ROS-1 gene alteration. Xalkori is the first and only FDA approved treatment for patients with ROS-1 positive NSCLC.
Read more: FDA expands use of Xalkori to treat rare form of advanced non-small cell lung cancer

US FDA News: Statement by FDA Commissioner Scott Gottlieb, M.D., and Biologics Center Director Peter Marks, M.D., Ph.D. on FDA’s continued efforts to stop stem cell clinics and manufacturers from marketing unapproved products that put patients at risk

FDA statement on stem cell enforcement actions and agency activities to facilitate legitimate product development
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D., and Biologics Center Director Peter Marks, M.D., Ph.D. on FDA’s continued efforts to stop stem cell clinics and manufacturers from marketing unapproved products that put patients at risk

US FDA News: Federal judge enters order of permanent injunction against Paul W. Franck

The U.S. Food and Drug Administration today announced that U.S. District Judge Carlos E. Mendoza entered an order of permanent injunction against Paul W. Franck of Ocala, Florida. According to the complaint filed with the consent decree, Franck manufactured and distributed drug products that were adulterated and misbranded in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act). The U.S. Department of Justice brought the action on behalf of the FDA.
Read more: Federal judge enters order of permanent injunction against Paul W. Franck

US FDA News: FDA issues final rule on safety and effectiveness of consumer hand sanitizers

FDA issues a final rule designed to help ensure that hand sanitizers available over-the-counter are safe and effective for those who rely on them. The rule establishes that certain active ingredients are not allowed to be used in OTC hand sanitizers, formally known as topical consumer antiseptic rub
Read more: FDA issues final rule on safety and effectiveness of consumer hand sanitizers

US FDA News: La FDA impulsa la Iniciativa de la Medicina de Precisión emitiendo guías preliminares para las pruebas basadas en la secuenciación de nueva generación

El día de hoy, en apoyo a la Iniciativa de Medicina de Precisión del Presidente, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) emitió dos guías preliminares que, una vez finalizadas, ofrecerán un procedimiento flexible para la supervisión de las pruebas que detectan diferencias de importancia médica en la composición genómica de una persona.
Read more: La FDA impulsa la Iniciativa de la Medicina de Precisión emitiendo guías preliminares para las pruebas basadas en la secuenciación de nueva generación

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on ongoing efforts to stop the spread of illicit opioids, further secure the U.S. drug supply chain and forcefully confront opioid epidemic

FDA issues first warning letter under Drug Supply Chain Security Act to McKesson Corp. for violations highlighted by a concerning tampering incident.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on ongoing efforts to stop the spread of illicit opioids, further secure the U.S. drug supply chain and forcefully confront opioid epidemic

US FDA News: FDA grants accelerated approval to first drug for Duchenne muscular dystrophy

The U.S. Food and Drug Administration today approved Exondys 51 (eteplirsen) injection, the first drug approved to treat patients with Duchenne muscular dystrophy (DMD). Exondys 51 is specifically indicated for patients who have a confirmed mutation of the dystrophin gene amenable to exon 51 skipping, which affects about 13 percent of the population with DMD.
Read more: FDA grants accelerated approval to first drug for Duchenne muscular dystrophy

US FDA News: FDA announces Project Facilitate to assist physicians seeking access to unapproved therapies for patients with cancer

The FDA Oncology Center of Excellence announced a new pilot program to assist oncology health care professionals in requesting access to unapproved therapies for patients with cancer.
Read more: FDA announces Project Facilitate to assist physicians seeking access to unapproved therapies for patients with cancer

US FDA News: FDA approves Eucrisa for eczema

The U.S. Food and Drug Administration today approved Eucrisa (crisaborole) ointment to treat mild to moderate eczema (atopic dermatitis) in patients two years of age and older.
Read more: FDA approves Eucrisa for eczema

US FDA News: FDA approves first generics of Lyrica

FDA approves first generics of Lyrica (pregabalin)
Read more: FDA approves first generics of Lyrica

US FDA News: FDA alerts consumers of nationwide voluntary recall of EpiPen and EpiPen Jr

The U.S. Food and Drug Administration is alerting consumers to Meridian Medical Technologies’ voluntary recall of 13 lots of Mylan’s EpiPen and EpiPen Jr (epinephrine injection) Auto-Injector products used for emergency treatment of severe allergic reactions. This recall is due to the potential that these devices may contain a defective part that may result in the devices’ failure to activate. The recalled product was manufactured by Meridian Medical Technologies and distributed by Mylan Specialty.
Read more: FDA alerts consumers of nationwide voluntary recall of EpiPen and EpiPen Jr

US FDA News: Trump Administration Combating Epidemic of Youth E-Cigarette Use with Plan to Clear Market of Unauthorized, Non-Tobacco-Flavored E-Cigarette Products

: FDA intends to finalize compliance policy that would prioritize enforcement of premarket authorization requirements for non-tobacco-flavored e-cigarettes, clearing the market these products.
Read more: Trump Administration Combating Epidemic of Youth E-Cigarette Use with Plan to Clear Market of Unauthorized, Non-Tobacco-Flavored E-Cigarette Products

Pharma Reviews: ICRA cuts outlook on Indian pharma

Mumbai: ICRA has revised its outlook on the domestic pharmaceutical industry from stable to negative in view of the lockouts in parts of China, amid ...
Read more: ICRA cuts outlook on Indian pharma

Pharma Reviews: Govt to reveal steps on trade issues over coronavirus soon, FM chairs meet

Earlier in the day, the industry body, Federation of Indian Chambers of ... The pharma industry, one of the worst affected in the weeks after the ...
Read more: Govt to reveal steps on trade issues over coronavirus soon, FM chairs meet

Pharma Reviews: With China being hit by coronavirus, India should look at positioning itself as alternative supply ...

With many industrial sectors, including pharma, staring at shortage of raw materials due to the coronavirus epidemic in China, industry body Ficci on ...
Read more: With China being hit by coronavirus, India should look at positioning itself as alternative supply ...

Pharma Reviews: Coronavirus: Pharma dept seeks curbs on drug ingredients imported from China

The active ingredients required to make several drug formulations are largely imported to Indian pharmaceutical companies from China.
Read more: Coronavirus: Pharma dept seeks curbs on drug ingredients imported from China

Pharma Reviews: Coronavirus Updates: 8 Indians aboard cruise ship in Japan infected with coronavirus, says MEA

Medical workers wearing protective gear move a patient suspected of ... The Indian pharmaceuticals industry has deep linkages to China, given its ...
Read more: Coronavirus Updates: 8 Indians aboard cruise ship in Japan infected with coronavirus, says MEA

US FDA News: FDA Announces Collaborative Review of Scientific Evidence to Support Associations Between Genetic Information and Specific Medications

FDA is providing its view of the state of the current science in pharmacogenetics. FDA’s new web-based resource describes some of the gene-drug interactions for which it believes there is sufficient scientific evidence to support associations between certain genetic variants & specific medications.
Read more: FDA Announces Collaborative Review of Scientific Evidence to Support Associations Between Genetic Information and Specific Medications

US FDA News: FDA Works to Ensure Smooth Regulatory Transition of Insulin and Other Biological Products

Today, the U.S. Food and Drug Administration took additional steps to ensure a smooth regulatory transition aimed at increasing patient access to insulin products, as well as certain other biological products set to transition regulatory pathways in March
Read more: FDA Works to Ensure Smooth Regulatory Transition of Insulin and Other Biological Products

Pharma Reviews: Icra revises domestic pharma industry outlook to negative due to coronavirus outbreak

Rating agency Icra on Thursday said it has revised its outlook on Indian pharmaceutical industry to negative from stable due to ongoing lockouts in ...
Read more: Icra revises domestic pharma industry outlook to negative due to coronavirus outbreak

Pharma Reviews: API makers surge up to 110% in 50 days as virus hits Chinese exports

The brokerage sees the coronavirus crisis as a positive for companies like Granules India and Natco and negative for Sun Pharma, Lupin, Dr Reddy's ...
Read more: API makers surge up to 110% in 50 days as virus hits Chinese exports

Pharma Reviews: Coronavirus: Stocks that took a hit in India and those who smiled

Coronavirus: Stocks that took a hit in India and those who smiled ... For pharma companies like Sun Pharma, Lupin, Aurobindo Pharma and Dr ...
Read more: Coronavirus: Stocks that took a hit in India and those who smiled

Pharma Reviews: Coronavirus will not impact finished pharma products, says Indian Pharmaceutical Alliance

The coronavirus outbreak is unlikely to impact the finished pharma products in India, as least for the next four-five months, said Sudarshan Jain, ...
Read more: Coronavirus will not impact finished pharma products, says Indian Pharmaceutical Alliance

Pharma Reviews: Shares snap 4-day losses; Nifty crosses 12100

In the commodities market, Brent crude for April 2020 settlement rose 81 cents to $58.56 a barrel. Buzzing Indian Index: The Nifty Pharma index rose ...
Read more: Shares snap 4-day losses; Nifty crosses 12100

Pharma Reviews: Centre will continue price cap on drugs: Goyal

Union Commerce Minister's remarks come amid pharma companies ... India might be large, but in global pharma innovation market we are just 2 per ...
Read more: Centre will continue price cap on drugs: Goyal

Pharma Reviews: Stocks in news: Sterlite Tech, Asian Paints, GAIL and more

This was on back of India Pharmaceutical Alliance (IPA) that described the situation in terms of raw material import from China as "grim" and added ...
Read more: Stocks in news: Sterlite Tech, Asian Paints, GAIL and more

Pharma Reviews: Coronavirus Impact: A long shutdown in China will leave a mark on key sectors

The Indian pharmaceuticals industry has deep linkages to China, given its reliance on China for critical elements of a drug's supply chain, starting from ...
Read more: Coronavirus Impact: A long shutdown in China will leave a mark on key sectors

Pharma Reviews: India lists 38 drug raw materials for which it wants to end dependence on China

... leaders of the Indian pharmaceutical industry to boost the manufacturing of these raw materials, which are scientifically called active pharmaceutical ...
Read more: India lists 38 drug raw materials for which it wants to end dependence on China

US FDA News: ResMed Recalls Stellar 100 and 150 Non-invasive and Invasive Ventilators Due to Sound Alarm Failure

The ventilators are used on patients that need breathing support. The sound alarm on the ventilator may fail to alert, presenting a risk of injury or death.
Read more: ResMed Recalls Stellar 100 and 150 Non-invasive and Invasive Ventilators Due to Sound Alarm Failure

Pharma Reviews: Impact likely on India Inc if coronavirus issue drags beyond April: Sanjay Dongre, UTI AMC

Also, Indian companies have proved in the past that they are credible ... There is also talk on the dependence of Indian pharma and chemical space ...
Read more: Impact likely on India Inc if coronavirus issue drags beyond April: Sanjay Dongre, UTI AMC

Pharma Reviews: Three militants killed in Tral gunfight

The Indian pharma industry heavily relies on imports of bulk drugs (Active Pharmaceutical Ingredient and intermediates), with 70 per cent of API ...
Read more: Three militants killed in Tral gunfight

Pharma Reviews: Patent applications to be approved in a record time to enable industry to discover innovative drugs ...

Replying to a question raised by Telangana Minister for Industries K T Rama Rao (KTR) that how the Indian Pharma and biotech industry to grow at a ...
Read more: Patent applications to be approved in a record time to enable industry to discover innovative drugs ...

Pharma Reviews: Indian firms may offer 9.1% pay hike, lowest in decade

Barring 2009, when Indian companies witnessed an average 6.6% hike in ... while pharma and IT companies will offer 9.9% and 9.6%, respectively.
Read more: Indian firms may offer 9.1% pay hike, lowest in decade

Pharma Reviews: India could face drug shortage by mid-March if coronavirus-hit China can't resume production

New Delhi: Every “single” Indian pharma company will be impacted by shortage of raw materials if coronavirus-hit China fails to resume drug ...
Read more: India could face drug shortage by mid-March if coronavirus-hit China can't resume production

Pharma Reviews: Govt mulls move to tackle corona effect on economy

That's why, the source said, the industry is seeking a reduction in the ... of shortage of medicines or medical equipment, instead the pharma industry is ... The Confederation of Indian Industry (CII) said in a report that India as well as ...
Read more: Govt mulls move to tackle corona effect on economy

Pharma Reviews: Reinventing the Indian pharma business is imperative: EY report

New Delhi: As Indian pharma companies prepare to shift from supplying commodities to supplying innovations, technology is altering the way health ...
Read more: Reinventing the Indian pharma business is imperative: EY report

Pharma Reviews: Coronavirus outbreak: API imports from China likely to be affected

The industry imports raw materials from China and though it's currently ... HYDERABAD: The Indian pharma industry is on the edge and could feel the ...
Read more: Coronavirus outbreak: API imports from China likely to be affected

Pharma Reviews: Share Market LIVE: Sensex up 280 points, Nifty above 12K; Bharti Infratel, Coal India top gainers

Share Market LIVE: Market benchmark indices Sensex and Nifty recovered ... Here's a look at the live updates of the market action on BSE and NSE today: ... (India) Ltd, Larsen & Toubro Infotech and Torrent Pharmaceuticals would ...
Read more: Share Market LIVE: Sensex up 280 points, Nifty above 12K; Bharti Infratel, Coal India top gainers

Pharma Reviews: Indian pharma & biotech industry expected to grow to 100 billion dollars by 2025: Piyush Goyal

Union Minister for Commerce and Industries Piyush Goyal has said that the Indian pharma and biotech industry is expected to grow to 100 billion ...
Read more: Indian pharma & biotech industry expected to grow to 100 billion dollars by 2025: Piyush Goyal

Pharma Reviews: 'Prices of key pharma ingredients could rise if coronavirus outbreak in China prolongs'

NEW DELHI: The prices of the key pharmaceutical ingredients could rise if the ... According to official sources, Indian drugmakers have informed the ...
Read more: 'Prices of key pharma ingredients could rise if coronavirus outbreak in China prolongs'

Pharma Reviews: e4m presents first edition of Health Communication Conference & Health Marcom Awards

Also hear from brands, companies and media agencies, who have contributed ... Sudarshan Jain - Secretary General, Indian Pharmaceutical Alliance; ...
Read more: e4m presents first edition of Health Communication Conference & Health Marcom Awards

Pharma Reviews: Coronavirus jolt to industry

Most of its manufacturing partners in China shut down operations due to the ... It further said China and India would experience severe impact.
Read more: Coronavirus jolt to industry

Pharma Reviews: Life sciences industry thriving: Piyush Goyal

Hyderabad: Indian pharma and biotech industry is expected to grow to $100 billion from the current size of about $40 billion, growing at 10 per cent ...
Read more: Life sciences industry thriving: Piyush Goyal

Pharma Reviews: Sun Pharma, others on regulator's radar as drugs flunk quality tests

The Indian drugs regulator found that two samples of Sun Pharmaceutical's antiviral medication valaciclovir hydrochloride have impurities.
Read more: Sun Pharma, others on regulator's radar as drugs flunk quality tests

Pharma Reviews: FM Sitharaman reviews coronavirus impact on domestic industry, promises measures to help India ...

Indian drug manufacturers are to a large extent dependent on China for sourcing their drug ingredients or the active pharmaceutical ingredients.
Read more: FM Sitharaman reviews coronavirus impact on domestic industry, promises measures to help India ...

Pharma Reviews: Sitharaman assesses India impact as coronavirus takes a bite of Apple

“The pharma sector is particularly vulnerable as it is a matter of health of Indian citizens, and also has an unduly high dependency on China," CII noted ...
Read more: Sitharaman assesses India impact as coronavirus takes a bite of Apple

Pharma Reviews: Lulu announces Rs 1000 cr investment in Indian food processing sector

Lulu announces Rs 1,000 cr investment in Indian food processing sector ... Patent applications to be approved in a record time to enable industry to ... in a record time to enable the pharma industry to discover innovative durgs.
Read more: Lulu announces Rs 1000 cr investment in Indian food processing sector

Pharma Reviews: Indian Pharma Industry Has Only Two To Three Months Stock Of Chinese APIs

Describing the situation in terms of raw material import from China as "grim," India Pharmaceutical Alliance said the Indian Pharma Industry has ...
Read more: Indian Pharma Industry Has Only Two To Three Months Stock Of Chinese APIs

Pharma Reviews: Govt to soon announce measures to deal with coronavirus impact on industry: FM

Various industry representatives, including those from pharma, textiles, ... shielding Indian exports to China; and boosting domestic manufacturing.
Read more: Govt to soon announce measures to deal with coronavirus impact on industry: FM

Pharma Reviews: UN chief visits Kartarpur gurdwara in Pakistan

Up to 5,000 Indian Sikhs have been allowed access daily through the ... India sources about 65-70 per cent of active pharmaceutical ingredients and ...
Read more: UN chief visits Kartarpur gurdwara in Pakistan

Pharma Reviews: IAF Aircraft to Evacuate Indians from Coronavirus Epicentre Wuhan on Thursday, Carry Medical ...

A number of industry representatives, including those from pharmaceuticals, textiles, chemicals electronics and IT hardware, solar, auto, surgical ...
Read more: IAF Aircraft to Evacuate Indians from Coronavirus Epicentre Wuhan on Thursday, Carry Medical ...

US FDA News: Colorado unapproved drug and dietary supplement makers ordered to cease operations for federal violations

Yesterday, U.S. District Judge Marcia S. Krieger for the U.S. District Court for Colorado entered a consent decree of permanent injunction against EonNutra LLC, CDSM LLC and HABW LLC, manufacturers and distributors of unapproved drugs and dietary supplements, and their owner, Michael Floren, requiring Floren’s businesses to immediately cease operations until they come into compliance with federal laws.
Read more: Colorado unapproved drug and dietary supplement makers ordered to cease operations for federal violations

US FDA News: FDA Takes Action with Indian Government to Protect Consumers From Illicit Medical Products

The FDA announced that in partnership with the Government of India, approximately 500 shipments of illicit and potentially dangerous, unapproved prescription drugs and combination medical devices were stopped from reaching American consumers.
Read more: FDA Takes Action with Indian Government to Protect Consumers From Illicit Medical Products

Pharma Reviews: Coronavirus threat: Pharma industry bodies seek implementation of Katoch Committee report

The uneasy calm among the Indian pharmaceutical companies only seems to worsen as WHO chief, Tedros Adhanom Ghebreyesus warned saying ...
Read more: Coronavirus threat: Pharma industry bodies seek implementation of Katoch Committee report

Pharma Reviews: Indian companies to offer average 9.1% pay hike in 2020, a decade low

As per the survey, while startups/e-commerce, services and pharma firms will be the top pay masters in 2020, sectors like logistics, infra, auto and ...
Read more: Indian companies to offer average 9.1% pay hike in 2020, a decade low

Pharma Reviews: Stringent regulatory and compliance requirements the top challenge when implementing digital for ...

As Indian pharma companies prepare to shift from supplying commodities to supplying innovations, technology is altering the way health care is ...
Read more: Stringent regulatory and compliance requirements the top challenge when implementing digital for ...

Pharma Reviews: Coronavirus: Paracetamol prices rise by 40% amid outbreak of deadly virus

The pharma sector in India could possibly be faced with shortages in ... TB at Lupin , Naresh Gupta one of the leading Indian pharma companies, says, ...
Read more: Coronavirus: Paracetamol prices rise by 40% amid outbreak of deadly virus

Pharma Reviews: Top-10 richest Indians | Mukesh Ambani continues to lead, but there's a new No 2

Forbes Real Times Billionaires Index released the list of India's billionaire and net ... Investments in the Indian capital market through participatory notes ... and multi-national pharma companies, said that most Indian companies are ...
Read more: Top-10 richest Indians | Mukesh Ambani continues to lead, but there's a new No 2

Pharma Reviews: Live: India to send medical supplies to virus-hit Wuhan, evacuate nationals

The minister also asked Indian steel companies to enhance output, ... The pharma industry could face shortages in finished drug formulations starting ...
Read more: Live: India to send medical supplies to virus-hit Wuhan, evacuate nationals

Pharma Reviews: BioAsia 2020 gathers industry stalwarts globally

... kicked off on 17th February, in the presence of stalwarts from Life Sciences, Biotechnology, Pharma and Healthcare industries in India and abroad.
Read more: BioAsia 2020 gathers industry stalwarts globally

Pharma Reviews: Coronavirus: Govt plans ban on 12 essential medicines to prevent shortage

Indian pharma majors such as Lupin, Sun Pharma and Dr. Reddy's do manufacture APIs but it is for captive use or used by pharmaceutical companies ...
Read more: Coronavirus: Govt plans ban on 12 essential medicines to prevent shortage

Pharma Reviews: Coronavirus outbreak: Enough drugs for any contingency, Indian pharma industry assures govt

Amid rising concerns over shortages of generic drugs in India due to coronavirus outbreak in China, pharma industry has assured government that ...
Read more: Coronavirus outbreak: Enough drugs for any contingency, Indian pharma industry assures govt

Pharma Reviews: Indian pharma industry needs to adopt digital technologies, says EY report

The average drug manufacturing utilisation rate in India is roughly 75 per cent across both active pharmaceutical ingredients (APIs) and formulation ...
Read more: Indian pharma industry needs to adopt digital technologies, says EY report

Pharma Reviews: India: Regulatory Action By CDSCO On Drug Adverse Events: A Year-end Review

NCC-PvPI identifies India centric drug safety signals after analyzing ... State/UT Drugs Controllers to instruct all the manufacturers licensed for the said ...
Read more: India: Regulatory Action By CDSCO On Drug Adverse Events: A Year-end Review

Pharma Reviews: Drugs prices likely to increase in India due to coronavirus in China

The prices of generic drugs in India are likely to increase due to the ... The Indian pharma industry heavily relies on imports of bulk drugs (Active ...
Read more: Drugs prices likely to increase in India due to coronavirus in China

Pharma Reviews: Paracetamol prices jump 40% in India as coronavirus epidemic shuts down China

The pharma industry could face shortages in finished drug formulations ... As manufacturers based in China restart factories, nations such as India ...
Read more: Paracetamol prices jump 40% in India as coronavirus epidemic shuts down China

Pharma Reviews: Coronavirus live updates: US evacuates its infected citizens

Indian hospital suspends biometric attendance over deadly virus scare ... The pharma industry could face shortages in finished drug formulations ...
Read more: Coronavirus live updates: US evacuates its infected citizens

Pharma Reviews: Gargi mass molestation case: Delhi HC seeks Centre's reply on plea demanding CBI probe

While noting that Indian imports are highly dependent on China, the ... India sources about 65-70 per cent of active pharmaceutical ingredients and ...
Read more: Gargi mass molestation case: Delhi HC seeks Centre's reply on plea demanding CBI probe

Pharma Reviews: Delhi AQI turns 'very poor', thunderstorms likely soon

The India Meteorological Department (IMD) recorded moderate fog in ... India sources about 65-70 per cent of active pharmaceutical ingredients and ...
Read more: Delhi AQI turns 'very poor', thunderstorms likely soon

Pharma Reviews: IPA to host 5th India Pharmaceutical Forum

Patient Centricity and Integrated Quality Management is the theme for this year's India Pharmaceutical Forum, organized by the Indian Pharmaceutical ...
Read more: IPA to host 5th India Pharmaceutical Forum

Pharma Reviews: China Shutdown to Ripple Across India From Drugs to Electronics

The pharma industry could face shortages in finished drug formulations starting April if supplies aren't restored by the first week of next month, he said.
Read more: China Shutdown to Ripple Across India From Drugs to Electronics

Pharma Reviews: As Jyotiraditya Scindia threatens, Kamal Nath dares him over protest

43 per cent of India's imports from the world coming from China. India sources about 65-70 per cent of active pharmaceutical ingredients and close to ...
Read more: As Jyotiraditya Scindia threatens, Kamal Nath dares him over protest

Pharma Reviews: Stocks to Watch: Bharti Airtel, Vodafone Idea, ONGC, Bank of Baroda, LIC Housing

The order relates to a case between Bank of Baroda and Indian Oil ... Granules India: The pharmaceutical company on Saturday said the US Food and ...
Read more: Stocks to Watch: Bharti Airtel, Vodafone Idea, ONGC, Bank of Baroda, LIC Housing

Pharma Reviews: Govt mulls export ban on 12 essential drugs

The committee sought data from leading pharmaceutical firms, industry associations like Indian Drug Manufacturers Association (IDMA), Indian ...
Read more: Govt mulls export ban on 12 essential drugs

Pharma Reviews: Novel coronavirus: The hunt for a virus killer

Serum Institute of India is teaming up with the US-based biotech company ... It is also giving top-up funding to Indian drug makers applying for CEPI ...
Read more: Novel coronavirus: The hunt for a virus killer

Pharma Reviews: Coranavirus grips China, Gujarat feels economic ripples

Bharat Gandhi, chairman of Federation of Indian Art Silk Weaving Industry ... Several pharma companies are running on the APIs inventory available ...
Read more: Coranavirus grips China, Gujarat feels economic ripples

Pharma Reviews: Hyderabad: Three-day BioAsia event in city from tomorrow

The event will host a series of discussions focusing on Indian life sciences and pharma Industry, Medical Devices and Digital Health, managing global ...
Read more: Hyderabad: Three-day BioAsia event in city from tomorrow

Pharma Reviews: Ficci: Some drugs may not last beyond Feb because of virus crisis

“Also, if the shutdown extends beyond February, then there may be some rise in prices of pharmaceutical products made in India,” the study said.
Read more: Ficci: Some drugs may not last beyond Feb because of virus crisis

Pharma Reviews: Coronavirus crisis: It's time for India Inc to create opportunities

Indian pharma industry is dependent on Chinese imports to make medicines — the APIs (active pharma ingredients) come from China. The $30 billion ...
Read more: Coronavirus crisis: It's time for India Inc to create opportunities

Pharma Reviews: Wockhardt-DRL deal: Habil Khorakiwala says Wockhardt divested 15 percent of total revenue

While talking about pharma's wish list from the government Habil ... I think that is very important is Indian pharma industry has been very competitive.
Read more: Wockhardt-DRL deal: Habil Khorakiwala says Wockhardt divested 15 percent of total revenue

Pharma Reviews: China's coronavirus paralyses pharma MSMEs in Baddi

New Delhi, Feb 15 (KNN) China's coronavirus has paralysed Indian pharmaceutical manufacturing companies as they depend heavily upon imports ...
Read more: China's coronavirus paralyses pharma MSMEs in Baddi

Pharma Reviews: Global summit on 'next-gen paradigms in health care' at Panjab University

Dr. Dinesh Dua, Chairman Pharmexcil was guest of honor and in his inaugural address, he presented the current scenario of Indian pharma industry.
Read more: Global summit on 'next-gen paradigms in health care' at Panjab University

Pharma Reviews: Virus may hit 28% Indian imports

Mumbai: The country's construction, auto, chemicals and pharma sectors ... China accounted for around $73 billion, or 14%, of India's total imports of ...
Read more: Virus may hit 28% Indian imports

Pharma Reviews: UFlex closes Q3 of FY19-20 with 57% Higher PAT YoY

Some key product launches that UFlex feels will change the way the market ... Innovations for Pharma Packaging: In order to value add to pharma industry, the ... A product that largely targets Indian customers has found takers in ...
Read more: UFlex closes Q3 of FY19-20 with 57% Higher PAT YoY

Pharma Reviews: Indian pharma cos want Chinese imports tested

Industry body Indian Drug Manufacturers' Association (IDMA) recently raised concerns about the possible spread of an infection, and wanted the ...
Read more: Indian pharma cos want Chinese imports tested

US FDA News: FDA Approves Three Drugs for Nonprescription Use Through Rx-to-OTC Switch Process

FDA Approves Three Drugs for Nonprescription Use Through Rx-to-OTC Switch Process
Read more: FDA Approves Three Drugs for Nonprescription Use Through Rx-to-OTC Switch Process

US FDA News: FDA’s Actions in Response to 2019 Novel Coronavirus at Home and Abroad

FDA is an active partner in the COVID-19 response, working closely with government and public health partners across HHS and international counterparts.
Read more: FDA’s Actions in Response to 2019 Novel Coronavirus at Home and Abroad

Pharma Reviews: Why Women Entrepreneurs Are Still Outliers in India

On the Index of Women Entrepreneurs, India ranks 52 out of 57 countries. ... The Baidyanath [Indian pharmaceutical giant specializing in Ayurvedic ...
Read more: Why Women Entrepreneurs Are Still Outliers in India

Pharma Reviews: Will the Wockhardt move help Dr Reddy's break into the big league?

Given much of the spend on medicines in India is out-of-pocket, the market is price sensitive, in addition to government drug price controls. But once ...
Read more: Will the Wockhardt move help Dr Reddy's break into the big league?

Pharma Reviews: The coronavirus effect: Dependence on Chinese raw materials puts Indian drug makers at risk

In the third week of January, a team from a leading Indian drug maker was on a visit to a Chinese vendor's chemical-manufacturing site in Anhui to ...
Read more: The coronavirus effect: Dependence on Chinese raw materials puts Indian drug makers at risk

Pharma Reviews: Lupin launches Moxifloxacin Ophthalmic Solution USP 0.5%

The product would be manufactured at Lupin's Pithampur (Unit-II) facility, India. Moxifloxacin Ophthalmic Solution USP, 0.5% is the AT2-rated generic ...
Read more: Lupin launches Moxifloxacin Ophthalmic Solution USP 0.5%

Pharma Reviews: AstraZeneca says 2020 sales growth to take coronavirus hit

The company said the guidance assumed an unfavourable impact from China lasting up to a few months as a result of the outbreak, which has killed ...
Read more: AstraZeneca says 2020 sales growth to take coronavirus hit

Pharma Reviews: 6 facts about Dilip Shanghvi, the billionaire who once overtook Mukesh Ambani as India's richest ...

It was this acquisition that made Sun Pharma the largest pharmaceutical company in India, largest Indian pharma company in the US and the 5th ...
Read more: 6 facts about Dilip Shanghvi, the billionaire who once overtook Mukesh Ambani as India's richest ...

Pharma Reviews: Indian pharma cos may face supply shortages from China if coronavirus drags on

Shortages and potential price increases of generic drugs from India loom if the coronavirus outbreak disrupts suppliers of pharmaceutical ingredients ...
Read more: Indian pharma cos may face supply shortages from China if coronavirus drags on

Pharma Reviews: BIMSTEC conference: Need to remove narcotics from pharma industry, says Amit Shah

BIMSTEC conference: Need to remove narcotics from pharma industry, says ... He stated that India would not allow illicit narcotics and psychotropic ...
Read more: BIMSTEC conference: Need to remove narcotics from pharma industry, says Amit Shah

Pharma Reviews: Coronavirus outbreak: D-Street feels the heat, but these 8 stocks may get advantage

India imports large amounts of raw materials & semi-finished goods for sectors like auto, pharma (APIs), consumer durables and electronics. Costs are ...
Read more: Coronavirus outbreak: D-Street feels the heat, but these 8 stocks may get advantage

Pharma Reviews: Traders' Diary: Follow 'buy on dips' strategy

The pharma sector is witnessing strong buying interest and the momentum is ... Shares of Indian Railway Catering & Tourism Corporation (IRCTC), ...
Read more: Traders' Diary: Follow 'buy on dips' strategy

Pharma Reviews: Explained: Reading medical device rules

Among the information that the manufacturer has to upload are “name ... This would mean that every medical device, either manufactured in India or ...
Read more: Explained: Reading medical device rules

US FDA News: Belviq, Belviq XR (lorcaserin) by Eisai: Drug Safety Communication - FDA Requests Withdrawal of Weight-Loss Drug

FDA has requested that the manufacturer voluntarily withdraw the weight-loss drug from the U.S. market because a safety clinical trial shows an increased occurrence of cancer. The drug manufacturer, Eisai Inc,. has submitted a request to voluntarily withdraw the drug.
Read more: Belviq, Belviq XR (lorcaserin) by Eisai: Drug Safety Communication - FDA Requests Withdrawal of Weight-Loss Drug

Pharma Reviews: What Will Be the Spillover Effects of the Coronavirus on India Inc?

In the last few days, major players in India's pharma and mobile phones industries have noted how if the shutdown continues, local production and ...
Read more: What Will Be the Spillover Effects of the Coronavirus on India Inc?

Pharma Reviews: Rajmohan Gandhi disputes Modi blaming Nehru for Partition, end Shaheen Bagh protest, says HT

When it comes to India's pharma industry and “the vast solar power revolution underway”, we are heavily dependent on China, explains Khanna.
Read more: Rajmohan Gandhi disputes Modi blaming Nehru for Partition, end Shaheen Bagh protest, says HT

Pharma Reviews: Market drifts lower

Among stocks, Indian Railway Catering & Tourism Corporation jumped ... Pharma USA Inc, which is an arm of the Indian pharmaceutical company.
Read more: Market drifts lower

Pharma Reviews: India seeks higher get right of entry to to Vietnam pharma marketplace

New Delhi: India has requested Vietnam to open its pharmaceutical marketplace for the Indian generic medication and sought higher marketplace get ...
Read more: India seeks higher get right of entry to to Vietnam pharma marketplace

Pharma Reviews: Opinion | We must brace for the economic fallout of coronavirus

Crucially, Chinese imports are powering India's pharma industry and the vast solar power revolution underway. Mint reported last week that solar ...
Read more: Opinion | We must brace for the economic fallout of coronavirus

Pharma Reviews: Government's medical devices move: Industry expresses concern over compliance costs

Indian medical devices industry expressed concern over government notification to regulate all medical devices as drugs, on grounds that the move ...
Read more: Government's medical devices move: Industry expresses concern over compliance costs

Pharma Reviews: Economy: Factory Shutdowns Show Why Nirmala Sitharaman's Tax Breaks Won't Work

For the latest news and more, follow HuffPost India on Twitter, Facebook, ... “While Pharma industries have shifted their domestic production to other ...
Read more: Economy: Factory Shutdowns Show Why Nirmala Sitharaman's Tax Breaks Won't Work

US FDA News: Medtronic Recalls MiniMed Insulin Pumps for Incorrect Insulin Dosing

Missing or broken retainer ring could cause under or over delivery of insulin. This may cause patient injury or death.
Read more: Medtronic Recalls MiniMed Insulin Pumps for Incorrect Insulin Dosing

Pharma Reviews: Modi govt halts plan to stop medicine export as firms in coronavirus-hit China resume work

The move came after Indian drugmakers informed the committee during a meet Monday that they have active pharmaceutical ingredients (APIs) stocks ...
Read more: Modi govt halts plan to stop medicine export as firms in coronavirus-hit China resume work

Pharma Reviews: These 10 multibaggers are off to a flying start in 2020 after tepid 2019

“If you look at the entire pharma space what we have been bullish has been on companies which have got significant business in India. If there is a ...
Read more: These 10 multibaggers are off to a flying start in 2020 after tepid 2019

Pharma Reviews: Stocks To Watch: Ashok Leyland, Coal India, Glenmark Pharma, Hindalco Industries, IDBI Bank ...

Asian stocks opened in mixed fashion Wednesday as investors weighed the spreading coronavirus against expectations for policy support. Treasuries ...
Read more: Stocks To Watch: Ashok Leyland, Coal India, Glenmark Pharma, Hindalco Industries, IDBI Bank ...

Pharma Reviews: Drug shortages due to coronavirus: India has API stocks for two-three months

India has enough stocks of API (active pharmaceutical ingredient) for about two-three months, industry representatives of drug companies say.
Read more: Drug shortages due to coronavirus: India has API stocks for two-three months

Pharma Reviews: 'Telecom Man' is Story of BK Syngal, the Father of Internet in India and the Revolution

Millions of lives all over the world have been saved by the innovation of Indian generic pharma companies. With a majority of pills consumed around ...
Read more: 'Telecom Man' is Story of BK Syngal, the Father of Internet in India and the Revolution

Pharma Reviews: FOCUS: Any drug export ban on China virus fear could be “disaster”

Indian pharmaceutical companies depend on China for procuring 65-70% of their raw material needs. On an average, Indian companies import close ...
Read more: FOCUS: Any drug export ban on China virus fear could be “disaster”